Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization.
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its Covid-19 vaccine within "weeks," its chief executive told Reuters, after the shot on Monday (Nov 1) received its first emergency use authorisation (EUA) from Indonesia. Novavax shares were up about 13 per cent after the company also said it had filed an application for.